New York Oncology Hematology PC-Hudson — Hudson, New York

New York Oncology Hematology PC-Hudson is a clinical research site located in Hudson, New York, United States 12534.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology PC-Hudson has participated in 14 clinical trials with 4 currently active.

Therapeutic areas: Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma, Recurrent Uterine Corpus Carcinoma.

Sponsors: National Cancer Institute (NCI), GOG Foundation, NSABP Foundation Inc.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology PC-Hudson?

New York Oncology Hematology PC-Hudson has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology PC-Hudson conducted?

New York Oncology Hematology PC-Hudson has 14 clinical trials on record, with 4 currently active. Their work covers Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma, Recurrent Uterine Corpus Carcinoma.

Is New York Oncology Hematology PC-Hudson accredited by Crixeo Health?

Yes — New York Oncology Hematology PC-Hudson holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York Oncology Hematology PC-Hudson?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.